Although amyloid-β peptide is the primary trigger of AD according to the amyloid cascade hypothesis [39], neurofibrillary degeneration of abnormally hyperphosphorylated tau is apparently required for the clinical expression of this disease [40]. The gene discussed is MAPT; the disease is Alzheimer disease.